EXAMINE THIS REPORT ON LINK ALTERNATIF MBL77

Therapy for relapsed/refractory disease must be decided depending on prior therapy as well as The explanation why the initial remedy was now not ideal (e.g., refractoriness vs. intolerance). Ibrutinib is the current gold standard therapy for patients with relapsed/refractory illness, according to the final results of various section I-III trials, 1